Velocimed developed multiple unique interventional cardiology products, including a proximal embolic protection device (Proxis™), a patent foramen ovale (“PFO”) closure device (PremereTM) and a directional catheter (VentureTM) for navigating tortuous vasculature. Each of these products was aimed at improving the safety and/or efficacy of certain interventional cardiology procedures.

Acquired by St. Jude Medical (now a subsidiary of Abbott Laboratories) in April 2005.